- Report
- June 2024
- 200 Pages
Global
From €7252EUR$7,950USD£6,199GBP
- Report
- January 2022
- 60 Pages
Global
From €3603EUR$3,950USD£3,080GBP
Throat cancer is a type of cancer that affects the throat, voice box, and other parts of the throat. It is a form of head and neck cancer and is typically treated with surgery, radiation, and chemotherapy. Oncology drugs are used to treat cancer, including throat cancer. These drugs can be used to reduce the size of tumors, reduce the spread of cancer, and reduce the side effects of cancer treatments.
Oncology drugs for throat cancer can be divided into two categories: targeted therapies and immunotherapies. Targeted therapies are designed to target specific cancer cells, while immunotherapies are designed to boost the body's own immune system to fight cancer. These drugs can be used alone or in combination with other treatments.
The throat cancer drug market is a rapidly growing market, with new drugs being developed to treat this type of cancer. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more